The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5 million per quarter. This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.

Fifteen companies currently qualify for inclusion, with six filing in U.S dollars and nine in the Canadian currency.  In the United States,Kush Bottles (OTC: KSHB)  reported FY18-Q1 (the quarter ending 11/30/17) sales of $8.85 million, which represented growth of 258%. We have updated the Canadian list to reflect the recent results from CanniMed Therapeutics (TSX: CMED) (OTC: CMMDF), which reported sales of C$4.82 million for its FY17-Q4 ending 10/31/17, a 52% increase over the same quarter a year ago, and Namaste Technologies (CSE: N) (OTC: NXTTF), which reported sales of C$4.93 million for its FY18-Q1 ending 11/30/17), a 136% increase from the same quarter a year ago.

By mid-February, Aurora Cannabis, Canopy Growth (TSX: WEED) (OTC: TWMJF), GW Pharma (NASDAQ: GWPH) and MedReleaf (TSX: LEAF) (OTC: MEDFF) will report results for the quarter ending 12/31. GW Pharma has scheduled a call for February 5th after the close, while MedReleaf and Canopy Growth will host calls on February 13th and 14th, respectively.

Visit the Public Cannabis Company Revenue Tracker to see the complete list of qualifying companies.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email